LFMDP — LifeMD Inc Preferred Series A
NASDAQ · Healthcare · Health Information Services
$23.61
+$0.46 (+2.00%)
LifeMD Inc Preferred Series A (LFMDP) is a health information services company listed on NASDAQ. It is led by Justin Schreiber, based in 236 Fifth Avenue, New York, NY, United States, 10001, with about 347 employees. LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Latest reported LFMDP revenue for 2025-09-30 was $60.2M. Net income was -$3.6M. Revenue was down 4.0% from 2025-06-30 to 2025-09-30.
Use this LFMDP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LFMDP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LFMDP SEC filings page. Lician reads the product cache first so this HTML stays unique to LifeMD Inc Preferred Series A even when a live quote feed is slow.
About LifeMD Inc Preferred Series A
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
LFMDP Key Statistics
Market Cap
$0.00M
Volume
507
Previous Close
$23.15
Day Range
$23.15 – $23.17
EPS
$0.00
Revenue
$212.45M
Net Income
-$18.73M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+39.3%
Profit Margin
-8.8%
Employees
347
LFMDP Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $212.45M | $152.55M | $119.03M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$18.73M | -$17.84M | -$45.02M |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 |
Total Assets
$72.46M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$35.00M
Operating Cash Flow
$17.51M
Free Cash Flow
$0.00
LifeMD Inc Preferred Series A Company Information
- Chairman & CEO
- Justin Schreiber
- Headquarters
- 236 Fifth Avenue, New York, NY, United States, 10001
- Website
- lifemd.com
- Phone
- 866 351 5907
- IPO / Founded
- 2021-10-05
- Sector
- Healthcare
- Industry
- Health Information Services